Serial Number 90129398
606

Registration Progress

Application Filed
Aug 21, 2020
Under Examination
Jul 20, 2021
Approved for Publication
Jan 26, 2021
Published for Opposition
Jan 26, 2021
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark:
Previous Owner: Skyhawk Therapeutics, Inc.
Classes: 005

Trademark Image

Basic Information

Serial Number
90129398
Filing Date
August 21, 2020
Published for Opposition
January 26, 2021
Abandonment Date
August 26, 2024
Drawing Code
2

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Aug 26, 2024
Classes
005

Rights Holder

Skyhawk Therapeutics, Inc.

03
Address
180 3rd Avenue, Fifth Floor
Waltham, MA 02451

Ownership History

Skyhawk Therapeutics, Inc.

Original Applicant
03
Waltham, MA

Skyhawk Therapeutics, Inc.

Owner at Publication
03
Waltham, MA

Legal Representation

Attorney
Peter Kunin

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

45 events
Date Code Type Description Documents
Aug 26, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Aug 26, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Mar 9, 2024 NOAC E CORRECTED NOA E-MAILED Loading...
Mar 8, 2024 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Feb 26, 2024 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Feb 26, 2024 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Feb 20, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 20, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Feb 20, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jan 10, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 9, 2024 EX5G S SOU EXTENSION 5 GRANTED Loading...
Dec 18, 2023 EXT5 S SOU EXTENSION 5 FILED Loading...
Jan 9, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 18, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 20, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 18, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
May 18, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
May 18, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 4, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 2, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 2, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 2, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 25, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 23, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jun 23, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 23, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 4, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 2, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 2, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 2, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 20, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 6, 2021 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Feb 25, 2021 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Jan 26, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 26, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 6, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 22, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 22, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 22, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 22, 2020 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Dec 22, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Dec 17, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 26, 2020 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Sep 25, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 25, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals, namely, small molecule therapeutic preparations for the correction of RNA expression and alteration of RNA translation, used in the treatment of cancers and other diseases

Additional Information

Design Mark
The mark consists of a stylized downward facing arrow with an upside down triangle above the arrow

Classification

International Classes
005